Spanish Scientists Achieve Complete Eradication of Pancreatic Cancer Thanks to Combination of 3 Drugs
24 Articles
24 Articles
A new study by researchers in Spain has found that a “triple therapy” eliminates pancreatic tumors in mice. Pancreatic cancer is one of the most aggressive tumors with the worst prognosis, in part because it quickly develops resistance to treatment. But a new study from the Spanish National Cancer Research Center (CNIO) finds that it is possible to eliminate pancreatic tumors in mice and prevent them from coming back using triple combination the…
A breakthrough in the fight against pancreatic cancer comes from amazing results on laboratory models: the combination of three drugs has wiped out the disease, here are the results and possible implications in the near future
A group of scientists led by Dr. Mariano Barbacid, director of the Experimental Oncology Group of the National Center for Oncological Research (CNIO) of Spain, reported the progress of a study that allowed 100% elimination of pancreatic cancer in mice, one of the most deadly.The specialists said that pancreatic cancer is usually considered one of the most common, but at the same time it is one of the most complex to treat for oncologists.This is…
The research led by Dr. Mariano Barbacid represents one of the most hopeful advances of recent years in the fight against pancreatic cancer, one of the worst-prognostic tumors. His team has managed to develop a triple experimental therapy that completely eliminates tumors in animal models, also avoiding the appearance of resistances and relapses, one of the main obstacles of current treatments. To this achievement is added a key element: the abs…
A therapy that combines three drugs eliminates pancreatic cancer and prevents it from reappearing later, according to a research done in mice that lays the foundation for improving the treatment of the disease in people. Continue reading...
The Spanish researcher estimates that the first human tests will start in three years and will need an investment of 30 million euros
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium









